Search results for "Urtica"

showing 10 items of 130 documents

Interaction between C1-INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria.

1984

The C1-inactivator plays an important role not only in the initial phases of the complement system, but also in those of the coagulation, fibrinolysis and kinin systems. The present study was concerned with the reciprocal influence of decreased C1-inactivator levels in patients with hereditary angioneurotic edema (HANE, HAE). In 13 HANE-I patients there were significantly increased levels of the coagulation factors XII, XI, V, of plasminogen and of alpha 2-antiplasmin, while the factors IX and VII were decreased. Conversely, it emerged that in patients with markedly raised prephase factor levels, angioneurotic edema occurred in the presence of normal or only slightly decreased C1-inactivato…

medicine.medical_specialtyUrticariaHereditary angioneurotic edemamedicine.medical_treatmentDermatologyKininsComplement C1 Inactivator Proteinschemistry.chemical_compoundInternal medicineEdemaFibrinolysismedicineHumansAngioedemaFactor XIIAngioedemaFactor VIIbusiness.industryFibrinolysisGeneral MedicineKininBlood Coagulation FactorsEndocrinologyCoagulationchemistryImmunologymedicine.symptombusinessArchives of dermatological research
researchProduct

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study

2021

Background: Ligelizumab, a next-generation, humanized anti-immunoglobulin E (IgE) monoclonal antibody is in development as a treatment for patients with chronic spontaneous urticaria, whose symptoms are inadequately controlled with standard-of-care therapy. Objective: To evaluate the long-term safety and re-treatment efficacy of ligelizumab 240 mg in patients who completed the core study and extension study. Methods: This open-label, single-arm, long-term Phase 2b extension study was designed to assess patients who were previously administered various doses of ligelizumab, omalizumab or placebo in the Phase 2b, dose-finding core study and who presented with active disease after Week 32. In …

medicine.medical_specialtyUrticariaImmunologyLigelizumab610OmalizumabOmalizumabImmunoglobulin EPlaceboAntibodies Monoclonal HumanizedInternal medicineActive diseasemedicineImmunology and AllergyHumansIn patientChronic UrticariaAdverse effectbiologybusiness.industryExtension studyChronic spontaneous urticariaTreatment OutcomeLigelizumabbiology.proteinIgEbusiness600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheitmedicine.drug
researchProduct

Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.

2014

medicine.medical_specialtyUrticariaMEDLINESubstance PDermatologyAnxietySubstance PBiochemistrySeverity of Illness Indexchemistry.chemical_compoundText miningQuality of lifeDownregulation and upregulationInternal medicineGermanySeverity of illnessMedicineHumansMolecular Biologybusiness.industryDepressionDisease progressionCell BiologyUp-RegulationMulticenter studychemistryChronic DiseaseDisease ProgressionQuality of LifebusinessBiomarkersThe Journal of investigative dermatology
researchProduct

Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data.

2020

medicine.medical_specialtyUrticariabusiness.industryDermatologyGeneral MedicineOmalizumabOmalizumabReal world evidenceTreatment Outcomeclinical evaluation and treatmentAnti-Allergic AgentsChronic DiseasemedicineHumansChronic UrticariaIntensive care medicinebusinessdermatologic therapymedicine.drugPreliminary DataDermatologic therapyREFERENCES
researchProduct

Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria.

2004

medicine.medical_specialtyUrticariabusiness.industryThermometersImmunologyImproved methodCold urticariamedicine.diseaseDermatologySurgeryCold TemperatureSemiconductorsThermoelectric effectImmunology and AllergyMedicineHumansbusinessThe Journal of allergy and clinical immunology
researchProduct

Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA<sup>2</sup>LEN – ARIA Position Paper

2012

Concepts of disease severity, activity, control and responsiveness to treatment are linked but different. Severity refers to the loss of function of the organs induced by the disease process or to the occurrence of severe acute exacerbations. Severity may vary over time and needs regular follow-up. Control is the degree to which therapy goals are currently met. These concepts have evolved over time for asthma in guidelines, task forces or consensus meetings. The aim of this paper is to generalize the approach of the uniform definition of severe asthma presented to WHO for chronic allergic and associated diseases (rhinitis, chronic rhinosinusitis, chronic urticaria and atopic dermatitis) in …

medicine.medical_specialtybusiness.industryPublic healthImmunologymacromolecular substancesGeneral MedicineAtopic dermatitismedicine.disease3. Good health03 medical and health sciences0302 clinical medicine030228 respiratory systemDisease severityEpidemiologyImmunologymedicinePhysical therapyImmunology and AllergyPosition paperDisease process030212 general & internal medicineIntensive care medicinebusinessChronic urticariaAsthmaInternational Archives of Allergy and Immunology
researchProduct

Interleukin 1 Gene Polymorphisms Presumably Participate in the Pathogenesis of Chronic Spontaneous Autocreative Urticaria

2020

Recent studies underline a potential role of autoimmune and genetic disturbances in this disorder pathogenesis. Variants in genes related to inflammatory processes may possibly predispose to chronic spontaneous urticaria (CSU) occurrence. The objective of this study was to search for an association of Il1 genes polymorphisms with the pathogenesis of CSU. The examined group consisted of 153 unrelated chronic spontaneous autoreactive urticaria patients. The control group consisted of 104 unrelated healthy volunteers. In all studied subjects, IL1 rs1304037 and rs180058 polymorphisms were examined. The Urticaria Activity Score was used to assess disease intensity. The age of disease onset was a…

musculoskeletal diseasesbusiness.industryImmunologyHaplotypeInterleukinCell BiologyDiseaseinterleukin 1chronic urticariapolymorphismPathogenesis030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineVirologyImmunologyGenotypeMedicineAllelebusinessGeneChronic urticaria030215 immunologyJournal of Interferon and Cytokine Research
researchProduct

Exhaled Nitric Oxide Level in Pharynx Angioedema.

2022

Airway inflammation is related to increased nitric oxide production. It can be assessed noninvasively with exhaled nitric oxide measurement. As airway inflammation was supposed to be present in chronic urticaria and angioedema patients we hypothesized increased exhaled nitric oxide in this group. Twenty-six symptomatic chronic urticaria patients with an acute episode of pharynx angioedema (17 women and 9 men, median age 35) were included in the study group. None of the patients reported a history of asthma, allergic rhinitis or cigarette smoking. The control group consisted of 29 non-smoking healthy subjects (19 women and 10 men, median age 22) without any history of atopy. Exhaled nitric o…

nitric oxideimmune system diseasesangioedemaRMedicineGeneral Medicineangioedema; chronic urticaria; nitric oxideskin and connective tissue diseaseschronic urticariaJournal of clinical medicine
researchProduct

Laboratory evaluation of the effect of plant extracts on Tetranychus urticae Koch (Acariformes, Tetranychidae)

2005

Acetone extracts of Annona cherimola Mill., Melia azedarach L., Artemisia absinthium L. and Quassia spp., were tested in laboratory trials on young females of Tetranychus urticae Koch (Acariformes,Tetranychidae). In the post-infestation tests, extracts of Melia and Annona caused a high mortality of the target females (84% and 96% for Melia and Annona, respectively) after 24 hours and 100% for both extracts after 48 hours. On the other hand Artemisia extracts caused 84% mortality of females after 10 days even if the oviposition rate was statistically lower than in the controls (2.5 and 6.7 eggs/female/day for Artemisia and controls, respectively).

plant extracts Tetranychus urticae laboratory trials
researchProduct

Tracking mite trophic interactions by multiplex PCR

2020

Background A thorough knowledge of trophic webs in agroecosystems is essential to achieve successful biological pest control. Phytoseiid mites are the most efficient natural enemies of tetranychid mites, which include several important pests worldwide. Nevertheless, phytoseiids may feed on other food sources including other microarthropods, plants and even other phytoseiids (intraguild predation), which can interfere with biological control services. Molecular gut content analysis is a valuable tool for characterizing trophic interactions, mainly when working on microarthropods such as mites. We have designed new primers for Phytoseiidae, Tetranychidae and Thysanoptera identification and th…

trophic linksMitesPhytoseiidaebiologyThysanopteraPrey detectionBiological pest controlZoologyplantGeneral Medicinebiology.organism_classificationPredationprey detectionPredatory BehaviorInsect Sciencemolecular diet analysisAnimalsTetranychus urticaePest Control BiologicalMultiplex Polymerase Chain ReactionAcariAgronomy and Crop SciencePredatorIntraguild predationTrophic levelPest Management Science
researchProduct